Suven Life Sciences, a biopharmaceutical company, witnesses a rise in share prices on Monday after the board of directors have approved fund raising plan. The board has raised funds not exceeding USD 100 million or its equivalent of any other foreign/ Indian currencies by way of issue of securities to QIPs/ FCCBs/ other modes in accordance with SEBI guidelines and subject to necessary approvals from statutory authorities as may be required.

Shares of the company are trading at Rs 204.70, up Rs 3.85, or 1.92% at the Bombay Stock Exchange (BSE) on Monday at 3:23 p.m.

The scrip has touched an intra-day high of Rs 209.10 and low of Rs 199.10. The total volume of shares traded at the BSE is 349,811.